コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 NPR-A catalyzes the intracellular conversion of guanosin
2 NPR-A mediates the vasorelaxant effect of ANP in pulmona
3 Cells transiently expressing 967K or 1034F NPR-A displayed decreased cGMP production in response to
4 (all P<10(-6)), while cells expressing 541S NPR-A produced more cGMP compared with cells expressing
10 ation of the natriuretic peptide receptor-A (NPR-A) is hypothesized to mediate its desensitization in
11 NP) binds to natriuretic peptide receptor-A (NPR-A), a membrane guanylyl cyclase, and to natriuretic
12 the identified BP-associated variants affect NPR-A function, the cGMP response to ANP and BNP was mea
13 yclic guanosine monophosphate production and NPR-A gene expression in cultured rat aortic smooth musc
15 on of guanylyl cyclase (GC)-A, also known as NPR-A or NPR1, by cardiac natriuretic peptides (NPs).
17 NPR-C as a local decoy receptor attenuating NPR-A effects in the kidney, where these receptors are c
18 inked natriuretic peptide receptors A and B (NPR-A and -B), respectively, stimulates increases in int
21 Intervention strategies aimed at controlling NPR-A expression are limited by the paucity of studies i
25 atriuretic peptide receptor 1 gene, encoding NPR-A, atrial natriuretic peptide receptor 1) was recent
28 eased affinity and full agonist activity for NPR-A, whereas one was as potent as any NPR-A activator
31 To further increase the potency of CD-NP for NPR-A, we converted two different triplet sequences with
33 tified six in vivo phosphorylation sites for NPR-A and five sites for NPR-B and demonstrated that the
34 fsANP and wtANP bound and activated human NPR-A and NPR-C similarly, whereas fsANP had a slightly
36 eductions were not explained by decreases in NPR-A protein levels, as indicated by immunoblot analysi
39 xpression was associated with an increase in NPR-A gene promoter activity that was critically depende
41 Sp1 sites previously shown to be involved in NPR-A promoter regulation, virtually eliminates NPR-A pr
42 hypercalcemic analogue RO-25-6760, increased NPR-A-dependent cyclic guanosine monophosphate productio
43 dual labeling immunocytochemistry localized NPR-A protein to cardiomyocytes, endocardial endothelial
45 biotinylation assays indicated that neither NPR-A nor NPR-B was internalized or degraded in response
54 significant downregulation in the density of NPR-A in heart and coronary artery of patients with isch
55 egrees C stimulated the dephosphorylation of NPR-A, and microcystin blocked the temperature-dependent
56 further stimulated the dephosphorylation of NPR-A, and microcystin failed to inhibit this process.
57 ains the ligand-dependent desensitization of NPR-A and NPR-B and characterized their trafficking prop
58 egulation account for the desensitization of NPR-A and NPR-B that occurs in response to various physi
59 icrocystin, inhibited the desensitization of NPR-A in membrane guanylyl cyclase assays in the absence
60 lly, we observed that the desensitization of NPR-A in membranes from mouse kidneys and NIH3T3 cells w
62 n sites within the kinase homology domain of NPR-A and determined that the conversion of these residu
66 e ligand-dependent trafficking properties of NPR-A remain controversial, whereas nothing is known abo
67 els of IDE profoundly alters the response of NPR-A and NPR-B to the stimulation of ANP, BNP, and CNP
68 ired changes in the phosphorylation state of NPR-A because the guanylyl cyclase activity of a recepto
73 stimulating cGMP production from cloned rat NPR-A (ED50 = 1.8 nM) and was reduced in NPR-C binding b
74 was only a slightly better activator of rat NPR-A due to the promiscuous nature of CNP in this speci
76 creased type A natriuretic peptide receptor (NPR-A) expression through a p38 MAPKbeta pathway in inne
77 on, the type A natriuretic peptide receptor (NPR-A) plays a major role in determining urinary sodium
78 of the type A natriuretic peptide receptor (NPR-A), a receptor that signals reductions in BP and sup
80 rmones inhibit natriuretic peptide receptors NPR-A or NPR-B in a variety of different cell types.
81 riuretic peptide (CNP)] and their receptors (NPR-A, NPR-B, NPR-C) at several early stages in the embr
82 guanylate cyclase (GC)-coupled NP receptors, NPR-A and NPR-B, whereas the third NP receptor, NPR-C, l
83 vely activate natriuretic peptide receptors, NPR-A and NPR-B, raising the cyclic GMP (cGMP) levels.
85 tor but was equally as potent in stimulating NPR-A-6E, suggesting that ATP is required to keep the wi
90 R subtypes have been described in brain: the NPR-A selectively binds ANP, whereas NPR-B exhibits high
92 ination of the VD-dependent induction of the NPR-A gene promoter but did not affect osmotic stimulati
95 on-dependent decrease in the activity of the NPR-A promoter in RASM cells confirming that endogenous
96 sequence CCAAT between -141 and -137 of the NPR-A promoter that, when mutated, reduces promoter acti
101 GMP compared with cells expressing wild-type NPR-A (P<=4.13x10(-5) for ANP and P<=4.24x10(-3) for BNP
103 orylation, we engineered a receptor variant (NPR-A-6E) containing glutamate substitutions at all six